Prolidase deficiency diagnosed by 1H NMR spectroscopy of urine

Journal of Inherited Metabolic Disease

Volumn 24, Issue 8, 2001, Pages 843-850

  Moolenaar, S H ^a   Engelke, U F H ^a   Abeling, N G G M ^b   Mandel, H ^c   Duran, M ^b   Wevers, R A ^a  

^a RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

^b ACADEMIC MEDICAL CENTER   (Netherlands)

^c RAMBAM MEDICAL CENTER   (Israel)

Author keywords

[No Author keywords available]

Indexed keywords

ALANYLPROLINE DERIVATIVE; GLYCYLPROLINE; HYDROXYPROLINE; PROLINE; PROLINE DIPEPTIDASE; PROTON;

AMINO ACID ANALYSIS; AMINO ACID URINE LEVEL; ARTICLE; CASE REPORT; ENZYME DEFICIENCY; HUMAN; PROTON NUCLEAR MAGNETIC RESONANCE; QUANTITATIVE ANALYSIS; URINALYSIS;

DIPEPTIDASES; DIPEPTIDES; HUMANS; HYDROGEN; MAGNETIC RESONANCE SPECTROSCOPY; METABOLISM, INBORN ERRORS; PROLINE; URINE;

EID: 0035719436     PISSN: 01418955     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1013940207973     Document Type: Article

References (24)

1. Prolidase deficiency: A multisystemic hereditary disorder
2. 1H-NMR spectroscopy
3. Proton NMR spectroscopic analysis of multiple acyl-CoA dehydrogenase deficiency-capacity of the choline oxidation pathway for methylation in vivo
4. Analysis of biological fluids using 600 MHz proton NMR spectroscopy: Application of homonuclear two-dimensional J-resolved spectroscopy to urine and blood plasma for spectral simplification and assignment
5. Clinical and biochemical characteristics of prolidase deficiency in siblings
6. A syndrome resembling lathyrism associated with iminodipeptidura
7. Prolidase deficiency
8. 1H NMR spectroscopy characterisation of the complex metabolic pattern of urine from patients with inborn errors of metabolism: 2-hydroxyglutaric aciduria and maple syrup urine disease
9. 3-Hydroxy-3-methylglutaryl-CoA lyase deficiency studied using 2-dimensional proton nuclear magnetic resonance spectroscopy
10. Analyses of iminodipeptides containing C-terminal proline or hydroxyproline in biological samples by liquid chromatography mass spectrometry
11. Prolidase deficiency: Detection of cases by a newborn urinary screening programme
12. NMR spectroscopy of biofluids
13. Increased manganese content and reduced arginase activity in erythrocytes of a patient with prolidase deficiency (iminodipeptiduria)
14. 1H NMR spectra of cerebrospinal fluid (CSF)
15. Prolidase deficiency among an Israeli population: Prenatal diagnosis in a genetic disorder with uncertain prognosis
16. Isotachophoretic analysis of iminodipeptides in the urine of patients with iminodipeptiduria
17. In vivo and in vitro NMR spectroscopy reveal a putative novel inborn error involving polyol metabolism
18. 13C NMR spectroscopy of human blood plasma
19. Disorders of proline and hydroxyproline metabolism
20. The use of liquid chromatography-mass spectrometry for the identification and quantification of urinary iminodipeptides in prolidase deficiency
21. Measurement of iminodipeptides in the serum of patients with prolidase deficiency using liquid chromatography-mass spectrometry
22. 1H-NMR spectroscopy of body fluids: Inborn errors of purine and pyrimidine metabolism
23. Prolidase deficiency: A patient without hydroxyproline-containing iminodipeptides in urine
24. Use of capillary zone electrophoresis for analysis of imidodipeptides in urine of prolidase-deficient patients